Categories: News

Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MALVERN, Pa., July 20, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release second quarter financial and operating results prior to market open on Tuesday, August 3, 2021. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

The conference call will be broadcast live in listen-only mode via a webcast on the Company’s investor relations website at ir.neuronetics.com. To listen to the conference call on your telephone, please dial (877) 472-8990 for United States callers or +1 (629) 228-0778 for international callers and reference confirmation code 8826628, approximately ten minutes prior to start time. The replay will be available on the Company’s website for approximately 60 days.

About Neuronetics

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Additional information can be found at www.neuronetics.com.

Investor Contact:

Mike Vallie or Mark Klausner
Westwicke Partners
443-213-0499
ir@neuronetics.com

Media Contact:

Chelsey Manko
Vault Communications
610-455-2778
cmanko@vaultcommunications.com

Staff

Recent Posts

Enhatch partners with 3D Systems to help power Smith + Nephew’s patient-specific ankle solutions

HASBROUCK HEIGHTS, N.J., April 1, 2025 /PRNewswire/ -- Enhatch, a leader in AI-powered preoperative planning…

5 hours ago

Apploi Ranks No. 30 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies in America

The Healthcare Workforce Management Platform Scales Ever-Higher with 221% Revenue Growth Over the Last Two…

5 hours ago

Covera Health Launches ‘Protect Her™’ – A Breakthrough AI Solution to Advance Early Detection in Women’s Health

New AI-powered platform leverages routine imaging to identify hidden health risks for women as they…

5 hours ago

Wellform MD is first in Iowa to Offer Leading-edge Technology Using Brain Stimulation to Treat Depression

Complimentary Launch Party April 24 to Showcase New Procedure ANKENY, Iowa, April 1, 2025 /PRNewswire/…

5 hours ago

LexisNexis Risk Solutions Expands Leadership Team with Fraud Prevention Expert Glenn Prager

Veteran Fraud Prevention Leader Joins LexisNexis Risk Solutions to Strengthen Program Integrity and Protect Public…

5 hours ago

Qanapi Innovates Data Security for Google Workspace

Qanapi Key Management Service for Google Workspace Now Available on Google Cloud Marketplace WASHINGTON, April…

5 hours ago